Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment

The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evidence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mild...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of heart failure Vol. 5; no. 2; pp. 66 - 81
Main Authors Youn, Jong-Chan, Kim, Darae, Cho, Jae Yeong, Cho, Dong-Hyuk, Park, Sang Min, Jung, Mi-Hyang, Hyun, Junho, Cho, Hyun-Jai, Park, Seong-Mi, Choi, Jin-Oh, Chung, Wook-Jin, Yoo, Byung-Su, Kang, Seok-Min
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Heart Failure 01.04.2023
대한심부전학회
Subjects
Review
내과학
Heart failure
Pharmacotherapy
Guideline
Treatment
Online AccessGet full text
ISSN2636-154X
2636-1558
2636-1558
DOI10.36628/ijhf.2023.0011

Cover

More Information
Summary:The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evidence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Jong-Chan Youn and Darae Kim contributed equally to this article as first authors.
ISSN:2636-154X
2636-1558
2636-1558
DOI:10.36628/ijhf.2023.0011